Ionis Pharmaceuticals IONS Available For Sale Securities Debt Maturities Total Percentage
Available For Sale Securities Debt Maturities Total Percentage at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:AvailableForSaleSecuritiesDebtMaturitiesTotalPercentage.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's available for sale securities debt maturities total percentage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's available for sale securities debt maturities total percentage?
- Ionis Pharmaceuticals (IONS) reported available for sale securities debt maturities total percentage of 100% in Q1 2026.
- How has Ionis Pharmaceuticals's available for sale securities debt maturities total percentage changed year-over-year?
- Ionis Pharmaceuticals's available for sale securities debt maturities total percentage decreased by 0.0% year-over-year, from 100% to 100%.
- What does available for sale securities debt maturities total percentage mean?
- The total percentage of the investment portfolio held in available-for-sale debt securities.
- How do you interpret available for sale securities debt maturities total percentage?
- An increase suggests a more conservative cash management strategy focused on fixed-income returns, while a decrease may indicate a shift toward cash equivalents or equity investments.
- How does available for sale securities debt maturities total percentage compare across companies?
- Biotech firms typically maintain high levels of liquid debt securities to fund long-term R&D cycles.